These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21510895)

  • 1. Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD.
    Lee J; Grizenko N; Bhat V; Sengupta S; Polotskaia A; Joober R
    BMC Psychiatry; 2011 Apr; 11():70. PubMed ID: 21510895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD.
    Thakur GA; Grizenko N; Sengupta SM; Schmitz N; Joober R
    BMC Psychiatry; 2010 Jun; 10():50. PubMed ID: 20569447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.
    Efron D; Jarman F; Barker M
    Pediatrics; 1997 Oct; 100(4):662-6. PubMed ID: 9310521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
    Efron D; Jarman F; Barker M
    Pediatrics; 1997 Dec; 100(6):E6. PubMed ID: 9382907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
    Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
    Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.
    Jain U; Hechtman L; Weiss M; Ahmed TS; Reiz JL; Donnelly GA; Harsanyi Z; Darke AC
    J Clin Psychiatry; 2007 Feb; 68(2):268-77. PubMed ID: 17335326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo response and its determinants in children with ADHD across multiple observers and settings: A randomized clinical trial.
    Fageera W; Traicu A; Sengupta SM; Fortier ME; Choudhry Z; Labbe A; Grizenko N; Joober R
    Int J Methods Psychiatr Res; 2018 Mar; 27(1):. PubMed ID: 28664541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial.
    Martins S; Tramontina S; Polanczyk G; Eizirik M; Swanson JM; Rohde LA
    J Child Adolesc Psychopharmacol; 2004; 14(2):195-206. PubMed ID: 15319017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Familial Correlation in Methylphenidate Response and Side Effect Profile.
    Gazer-Snitovsky M; Brand-Gothelf A; Dubnov-Raz G; Weizman A; Gothelf D
    J Atten Disord; 2019 Jan; 23(2):135-139. PubMed ID: 25899797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
    Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
    Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
    J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder.
    Biederman J; Quinn D; Weiss M; Markabi S; Weidenman M; Edson K; Karlsson G; Pohlmann H; Wigal S
    Paediatr Drugs; 2003; 5(12):833-41. PubMed ID: 14658924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Greenhill LL; Findling RL; Swanson JM;
    Pediatrics; 2002 Mar; 109(3):E39. PubMed ID: 11875167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder.
    Solanto M; Newcorn J; Vail L; Gilbert S; Ivanov I; Lara R
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):663-71. PubMed ID: 20035584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
    Vitiello B; Abikoff HB; Chuang SZ; Kollins SH; McCracken JT; Riddle MA; Swanson JM; Wigal T; McGough JJ; Ghuman JK; Wigal SB; Skrobala AM; Davies M; Posner K; Cunningham C; Greenhill LL
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):593-604. PubMed ID: 17979580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.
    Joober R; Grizenko N; Sengupta S; Amor LB; Schmitz N; Schwartz G; Karama S; Lageix P; Fathalli F; Torkaman-Zehi A; Ter Stepanian M
    Neuropsychopharmacology; 2007 Jun; 32(6):1370-6. PubMed ID: 17063150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Weiss M; Hechtman L; Turgay A; Jain U; Quinn D; Ahmed TS; Yates T; Reiz JL; Donnelly GA; Harsanyi Z; Darke AC
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):675-88. PubMed ID: 17979587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of methylphenidate in patients with cerebral palsy and attention-deficit hyperactivity disorder (ADHD).
    Gross-Tsur V; Shalev RS; Badihi N; Manor O
    J Child Neurol; 2002 Dec; 17(12):863-6. PubMed ID: 12593456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects.
    Buitelaar JK; van der Gaag RJ; Swaab-Barneveld H; Kuiper M
    J Child Psychol Psychiatry; 1996 Jul; 37(5):587-95. PubMed ID: 8807439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder.
    Szobot CM; Rohde LA; Katz B; Ruaro P; Schaefer T; Walcher M; Bukstein O; Pechansky F
    Braz J Med Biol Res; 2008 Mar; 41(3):250-7. PubMed ID: 18327433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.